• Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis

    Thursday January 6th 2022

  • Peter Scheyltjens (52), CEO en oprichter van de Advipro Groep, geeft de fakkel door aan zijn rechterhand Toon Witvrouwen (35)

    Thursday December 23rd 2021

  • VIB research at the basis of experimental gene therapy against dementia

    Wednesday December 22nd 2021

  • Biotalys and Biobest enter into strategic partnership to expand reach of novel biocontrol solutions

    Monday December 20th 2021

  • argenx announces U.S. Food and Drug Administration (FDA) approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis

    Monday December 20th 2021

  • UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis

    Friday December 10th 2021

  • Early detection of Omicron facilitated with Emweb's Genome Detective

    Friday December 10th 2021

  • Biocartis’ Idylla™ SARS-CoV-2 testing successfully detects Omicron variant

    Thursday December 9th 2021

  • Your news here?

  • MRM Health announces first patient dosed with next generation live microbiome consortia therapeutic MH002 in Phase 1b/2a study in patients with Ulcerative Colitis

    Wednesday December 8th 2021

  • Spectacular results with Japanese encephalitis vaccine of ViroVet

    Wednesday December 8th 2021

  • Sequana Medical announces the completion of patient enrolment in POSEIDON, the North American pivotal alfapump® study

    Tuesday December 7th 2021

Strategic Partners